---
title: "ZHENGGUANG and others established a biotechnology company in Ningbo"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263014691.md"
description: "According to the Qichacha APP, recently, Ningbo Zhengguang Biotechnology Co., Ltd. was established with a registered capital of 10 million yuan. The business scope includes: manufacturing of bio-based materials; sales of bio-based materials; sales of synthetic materials; sales of instruments and meters, etc. Qichacha's equity penetration shows that the company is jointly held by Zhengguang and others"
datetime: "2025-10-28T06:55:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263014691.md)
  - [en](https://longbridge.com/en/news/263014691.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263014691.md)
generator: "portal-rs"
---

# ZHENGGUANG and others established a biotechnology company in Ningbo

According to the Qichacha APP, recently, Ningbo Zhengguang Biotechnology Co., Ltd. was established with a registered capital of 10 million yuan. The business scope includes: manufacturing of bio-based materials; sales of bio-based materials; sales of synthetic materials; sales of instruments and meters, etc. Qichacha's equity penetration shows that the company is jointly held by Zhengguang and others

### Related Stocks

- [301092.CN](https://longbridge.com/en/quote/301092.CN.md)

## Related News & Research

- [BYD launches Sealion 08 SUV, bolstering Ocean lineup's flagship push](https://longbridge.com/en/news/297765654.md)
- [REG - NextEnergy Solar Fnd - Result of AGM](https://longbridge.com/en/news/298041368.md)
- [08:39 ETGraywind Manual Sliding Track Blinds 2.0 for Flexible Living Spaces](https://longbridge.com/en/news/298039910.md)
- [Meritage Announces Departure of Michael Ruggeri From Board of Directors | MHGU Stock News](https://longbridge.com/en/news/297965385.md)
- [Egetis says new Emcitate clinical data from Triac Trial II, ReTRIACt to be presented at September congresses](https://longbridge.com/en/news/297996002.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**